Pharmaceutical treatment for urinary tract infections (UTI) is significantly associated with a higher risk for a delayed diagnosis of muscle-invasive or metastatic bladder cancer. Treatment for ...
Suffering from recurrent urinary tract infections (UTIs) could signal more than a simple infection—it may be an early warning sign of kidney cancer, experts caution. Often called a “silent disease,” ...
Neutrophil tubulointerstitial infiltration (NTI) was identified in 10.2% of kidney transplant recipients and was associated with urinary tract infections (UTIs), female donor sex, delayed graft ...
The incidence of urinary tract infections after radical cystectomy differs according to how much time elapsed from discharge, with patients who experience UTIs 31-90 days post-discharge at higher ...
Adults with type 2 diabetes (T2D) who initiated empagliflozin treatment did not face a higher risk for urinary tract cancers (UTCs), such as bladder or renal cancer, than those who initiated DPP-4 ...